Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Vitara Biomedical logo — Because every day counts

Vitara Biomedical

Because every day counts

Founded 2019 United States Philadelphia, United States 65 employees Series B Total: $75.00M Care Economy, Health Care +1

General Information

Company Name Vitara Biomedical
Founded Year 2019
Location United States Philadelphia, United States
Employees 65
Industries Care Economy, Health Care, Medical Devices
Funding Stage Series B
Business Model B2B, B2D
Revenue Model Product Sales, Leasing/Rental, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Vitara Biomedical. To contact Vitara Biomedical, visit vitara.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vitara Biomedical compare?

A PDF of Vitara Biomedical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vitara Biomedical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vitara Biomedical

Vitara Biomedical, founded in 2019, is at the forefront of transforming the standard of care for extremely premature newborns. The company is driven by a clear mission, encapsulated in its slogan, "Because every day counts." By focusing on the Care Economy, Health Care, and Medical Devices industries, Vitara Biomedical aims to offer these vulnerable patients and their families expanded lifetime possibilities.

Headquartered in the United States, the company has attracted significant attention from high-profile investors. In its last funding round, a $75.00M Series B investment secured on 13 September 2022, investment participants included prominent names such as GV, Khosla Ventures, Sands Capital Ventures, First Spark Ventures, Fry’s Path Capital, The Children's Hospital of Philadelphia, Martin Varsavsky, and Flerie Invest. This strong backing signals confidence in the company's potential to revolutionize neonatal care with innovative medical solutions.

Business keywords: neonatal care, premature infants, therapeutic platform, biomedical innovation, physiological processes, preterm newborn support, medical innovation, neonatal technology, infant healthcare, newborn care solutions, family-centered care, pediatric healthcare, prematurity solutions, lifesaving therapies

Services & Products

Development of EXTEND Neonatal Support Technology
Providing a Fluid-Filled Environment for Premature Babies
Reinvention of Neonatal Care Standards

Target Customers

Neonatal Intensive Care Units (NICUs) Hospitals Healthcare Providers Families of Extremely Premature Babies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $50.00M 5
GV Khosla Ventures First Spark Ventures
GV, Khosla Ventures +3
01 Nov 2024
Early VC $25.00M -
01 Aug 2022

Vitara Biomedical Alternatives & Competitors

View All Alternatives
Vitara Biomedical vs
Innara Health
Innara Health United States

Improving feeding outcomes for newborns and infants born prematurely.

Venture round
8 employees
Health Care, Medical Devices
Compare Vitara Biomedical vs Innara Health
Vitara Biomedical vs
Bilihome
Bilihome The Netherlands

wearable jaundice therapy for natural newborn care

Seed
8 employees
Care Economy, Fashion
Compare Vitara Biomedical vs Bilihome
Vitara Biomedical vs
NeoLight, LLC
NeoLight, LLC United States

A company focused on empathy driven innovation

Venture round
46 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Vitara Biomedical

Because every day counts
Vitara Biomedical was founded in 2019.
Vitara Biomedical is headquartered in Philadelphia, United States.
Vitara Biomedical operates in Care Economy, Health Care and Medical Devices. Its work centres on neonatal care, premature infants, therapeutic platform and biomedical innovation. Its customers include Neonatal Intensive Care Units (NICUs), Hospitals and Healthcare Providers.
Vitara Biomedical has a B2B and B2D business model. Its revenue comes from Product Sales, Leasing/Rental and Service Fee.
Vitara Biomedical has approximately 65 employees.
Vitara Biomedical has completed 2 funding rounds, raising a total of $75.00M. The latest funding stage is Series B.
Vitara Biomedical offers: Development of EXTEND Neonatal Support Technology, Providing a Fluid-Filled Environment for Premature Babies, Reinvention of Neonatal Care Standards.
Top alternatives and competitors to Vitara Biomedical include Innara Health, Bilihome, NeoLight, LLC, The Children's Inn at NIH, Computational Life. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vitara Biomedical and Innara Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vitara Biomedical, https://bouncewatch.com/company/vitara-biomedical, updated 14 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout